Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2024-05-29
2024-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of Perioperative Acute Kidney Injury Incidence
NCT02521350
Evaluation of Postoperative Acute Kidney Injury (AKI) Incidence and Risk Factors in Patients Underwent Pneumonectomy
NCT05672238
Acute Renal Injury After Major Elective Non-Cardiac Surgery
NCT04600271
Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery
NCT05068167
Neutrophil Gelatinase-associated Lipocalin in Major Abdominal Surgery
NCT05721638
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is known that the serum creatinine level, which is routinely used to monitor renal functions, increases late and has poor sensitivity. The reason for this is that it begins to increase 48-72 hours after kidney damage begins and when 50% of functional neurons are lost. Cystatin C, produced by all nucleated cells, is freely filtered by the glomerulus and reabsorbed in the proximal tubule. It is not secreted by renal tubules and does not vary depending on gender, race, weight, changes in muscle mass and nutrition. Serum cystatin C is a biomarker that reflects glomerular filtration rate (GFR) well and can diagnose AKI more accurately than creatinine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Serum creatinine, GFR and blood urea nitrogen (BUN) values will be measured in all patients before surgery and 48 hours after removal of the renal pedicle clamp. Patients' blood and blood product replacement, vasopressor and inotrope needs will be recorded. Serum cystatin C level will be measured by taking serum samples before the surgery and at the 48th hour postoperatively.
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
R- fluid group
The group to which restrictive fluid replacement will be applied (Group R); 3 ml/kg/hour Ringer lactate (RL) solution will be given.
Restrictive
3 mL/kg/hour Ringer Lactate will be given peroperatively to the restrictive group (Group R).
L- fluid group
7 ml/kg/hour RL solution will be given to the group that will receive a liberal liquid regimen (Group L).
Liberal
7 ml/kg/hour Ringer Lactate will be given peroperatively to the liberal group (Group L).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Restrictive
3 mL/kg/hour Ringer Lactate will be given peroperatively to the restrictive group (Group R).
Liberal
7 ml/kg/hour Ringer Lactate will be given peroperatively to the liberal group (Group L).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The opposite kidney is in normal function
Exclusion Criteria
* Patients with preoperative chronic kidney disease,
* Those using preoperative medications known to cause renal toxicity such as aminoglycosides, aspirin and angiotensin converting enzyme inhibitors,
* Coronary artery disease
* Congestive heart failure
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muğla Sıtkı Koçman University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eylem Yaşar
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eylem Yasar, M.D
Role: PRINCIPAL_INVESTIGATOR
Mugla Sitki Kocman Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mugla Sitki Kocman Training and Research Hospital
Muğla, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yasar E, Toker MK, Saruhan E, Gursoy C. Impact of liberal versus restrictive fluid management on acute kidney injury after nephrectomy: a randomised controlled trial with cystatin C evaluation. BMC Urol. 2025 Oct 27;25(1):270. doi: 10.1186/s12894-025-01954-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mugla SKU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.